Viatris Inc. (VTRS) is a global healthcare company formed through the merger of Mylan and Upjohn (a division of Pfizer) in ...

An oncology-focused Pfizer is poised to grow over the coming years. Abundant (and growing) earnings protect the dividend despite an abnormally high yield. The stock's valuation signals that the ...

PF-07976016 is under clinical development by Pfizer and currently in Phase I for Obesity. According to GlobalData, Phase I drugs for Obesity have a 59% phase transition success rate (PTSR) indication ...

Be among those who shape the future with knowledge. Uncover exclusive stories that captivate your mind and heart with our FREE 14-day subscription trial. Dive into a world of inspiration, learning, ...

Marsha's career included working for Portage Northern High School and the Upjohn Company, which later became Pharmacia/Pfizer. However, her greatest accomplishment was the family she raised with love ...

Three students from Centreville High School in Clifton discovered a potentially harmful substance – DNA residues, or tiny fragments of genetic material – in Pfizer’s messenger RNA COVID-19 ...

However, at least two conditions listed as adverse events also appeared in Pfizer's 2024 list of genuine side effects. In January 2025, Snopes readers asked us about the authenticity of a long ...

NAIROBI, Kenya Jan 16 – Biotech and pharmaceutical company Pfizer has announced plans to reorganise its activities in Kenya amid emerging market dynamics. A company spokesperson said the ...

(Bloomberg) -- Pfizer Inc. sold about 700 million shares in Haleon Plc, further paring its stake in the maker of Sensodyne toothpaste. The deal raised around £2.5 billion ($3.1 billion ...

Pfizer PFE-2.06%decrease; red down pointing triangle has sold 700 million shares in British consumer-healthcare business Haleon HLN-0.11%decrease; red down pointing triangle for 2.50 billion ...

While presenting at the JP Morgan Healthcare Conference, Pfizer Inc. (NYSE:PFE) Albert Bourla, Chairman and CEO, said, “I think we did significant transformative changes in Pfizer.” ...